Selling And Administration Expenses Cambiamento Data
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
AstraZeneca USD 3.91B 194M 2023-09
Biogen USD 608.5M 179.7M 2023-12
Celldex Therapeutics USD 8.83M 611K 2023-12
Cipla INR 10.91B 245.2M 2023-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.29M 163K 2023-09
CSL USD 1.29B 219.4M 2023-06
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Grifols EUR 300.32M 28.7M 2023-09
Immunic USD 3.77M 75K 2023-09
Incyte USD 293.86M 25.97M 2023-12
Intrexon USD 9.2M 120K 2023-09
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Lexicon Pharmaceuticals USD 32.23M 2.22M 2023-09
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Merck USD 2.75B 272M 2023-12
Omeros USD 16.42M 5.16M 2023-09
Regulus Therapeutics USD 2.64M 298K 2023-09
Takeda JPY 252.95B 4.84B 2023-09



Regulus Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.